Venlafaxine 150mg ER Tablets

Venlafaxine 150mg is a serotonin-noradrenaline reuptake inhibitor used for depression and selected anxiety disorders. The extended-release formulation provides gradual delivery of venlafaxine during the day.
Take the extended-release tablet with food at a consistent time each day. Swallow it whole rather than crushing or chewing it. Dose reduction is gradual because sudden withdrawal can cause marked discontinuation symptoms.
Venlafaxine reduces the reuptake of serotonin and noradrenaline into nerve cells. Greater availability of these neurotransmitters supports mood and anxiety regulation over time.
Nausea, sweating, dry mouth, constipation, sleep changes, dizziness and sexual difficulties can occur. Severe agitation with fever or tremor, new suicidal thoughts, or a marked rise in blood pressure need urgent attention.
Blood pressure should be monitored, particularly after dose increases. MAO inhibitors and other serotonergic medicines can cause dangerous interactions. Bipolar disorder, narrow-angle glaucoma and low sodium risk are important before treatment. Alcohol may worsen impairment.
Can improve persistent low mood, excessive worry and associated disruption of daily functioning when an SNRI is appropriate.
Some symptoms may improve earlier, but a meaningful mood or anxiety response often takes several weeks rather than a single dose.
Dizziness, nausea, sleep disturbance, anxiety and electric-shock sensations can occur. A tailored taper helps reduce these effects.
No. Regular treatment reduces symptom burden over time; it is not a rapid-acting rescue sedative.
Reduced libido, delayed orgasm and ejaculation difficulties are recognised effects and can be discussed without abruptly stopping treatment.
Some extended-release tablets leave an inactive shell after releasing the medicine. This does not necessarily mean the dose was unabsorbed.
SNRI: serotonin-noradrenaline reuptake inhibitor. Neurotransmitter: a chemical messenger between nerve cells. Discontinuation symptoms: effects caused by reducing or stopping some medicines too quickly. Extended release: gradual delivery from a dosage form; AR: Venlafaxine 150mg أقراص ممتدة التحرر; FR: Venlafaxine 150mg comprimés à libération prolongée; PT: Venlafaxine 150mg comprimidos de libertação prolongada; ES: Venlafaxine 150mg comprimidos de liberación prolongada; RU: Venlafaxine 150mg таблетки пролонгированного высвобождения; ID: Venlafaxine 150mg tablet lepas lambat; VI: Venlafaxine 150mg viên nén giải phóng kéo dài; MS: Venlafaxine 150mg tablet pelepasan berpanjangan; TL: Venlafaxine 150mg tabletang may pinalawig na paglabas; ZH-SG: Venlafaxine 150mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Venlafaxine 150mg ER Tablets under Mental Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Venlafaxine 150mg ER Tablets